Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the full record of transactions filed by Sblendorio Glenn, Consejero. Director active across 5 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 32 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €2m. Activity tracked since 27 May 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sblendorio Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22.163 títulos@ 1,45 US$1.3% de su flujoCommon StockSEC:0001104659-21-153685:0
25 de 32 declaraciones
About Sblendorio Glenn
SBLENDORIO GLENN is Chief Executive Officer and Director. He has 32 filings in total, and in the sampled recent filings the reported volume is 0 in buys and 3782427 in sells, with transactions ranging from 2016-01-04 to 2026-04-27.